Pharmacokinetics of Tirzepatide Following Administration to Subjects With Impaired Renal Function
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2019
Price : $35 *
At a glance
- Drugs Tirzepatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 02 Sep 2019 Status changed from active, no longer recruiting to completed.
- 16 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 02 Aug 2019 Planned End Date changed from 26 Aug 2019 to 2 Sep 2019.